Display options
Share it on

Am J Nucl Med Mol Imaging. 2016 Nov 30;6(6):310-327. eCollection 2016.

Precision medicine and molecular imaging: new targeted approaches toward cancer therapeutic and diagnosis.

American journal of nuclear medicine and molecular imaging

Mojtaba Ghasemi, Iraj Nabipour, Abdolmajid Omrani, Zeinab Alipour, Majid Assadi

Affiliations

  1. The Persian Gulf Tropical Medicine Research Center, Bushehr University of Medical SciencesBushehr, Iran; Young Researchers and Elite Club, Bushehr Branch, Islamic Azad UniversityBushehr, Iran.
  2. The Persian Gulf Tropical Medicine Research Center, Bushehr University of Medical SciencesBushehr, Iran; The Future Studies Group, Iranian Academy of Medical SciencesTehran, Iran.
  3. Division of clinical studies, The Persian Gulf Nuclear Medicine Research Center, Bushehr University of Medical Sciences Bushehr, Iran.
  4. The Persian Gulf Nuclear Medicine Research Center, Bushehr University of Medical SciencesBushehr, Iran; Department of Molecular Imaging and Radionuclide Therapy (MIRT), Bushehr Medical University Hospital, Bushehr University of Medical SciencesBushehr, Iran.

PMID: 28078184 PMCID: PMC5218860

Abstract

This paper presents a review of the importance and role of precision medicine and molecular imaging technologies in cancer diagnosis with therapeutics and diagnostics purposes. Precision medicine is progressively becoming a hot topic in all disciplines related to biomedical investigation and has the capacity to become the paradigm for clinical practice. The future of medicine lies in early diagnosis and individually appropriate treatments, a concept that has been named precision medicine, i.e. delivering the right treatment to the right patient at the right time. Molecular imaging is quickly being recognized as a tool with the potential to ameliorate every aspect of cancer treatment. On the other hand, emerging high-throughput technologies such as omics techniques and systems approaches have generated a paradigm shift for biological systems in advanced life science research. In this review, we describe the precision medicine, difference between precision medicine and personalized medicine, precision medicine initiative, systems biology/medicine approaches (such as genomics, radiogenomics, transcriptomics, proteomics, and metabolomics), P4 medicine, relationship between systems biology/medicine approaches and precision medicine, and molecular imaging modalities and their utility in cancer treatment and diagnosis. Accordingly, the precision medicine and molecular imaging will enable us to accelerate and improve cancer management in future medicine.

Keywords: P4 medicine; Precision medicine; cancer theranostics; metabolomics-based systems medicine; molecular imaging; precision medicine initiative; radio-omics; systems biology

References

  1. Nature. 2000 Jun 15;405(6788):827-36 - PubMed
  2. Cancer Cell. 2002 Mar;1(2):203-9 - PubMed
  3. Cancer Cell. 2002 Feb;1(1):75-87 - PubMed
  4. Nature. 2002 Nov 14;420(6912):206-10 - PubMed
  5. Genes Dev. 2003 Mar 1;17(5):545-80 - PubMed
  6. Trends Genet. 2003 Oct;19(10):551-60 - PubMed
  7. J Nucl Med. 2004 Mar;45(3):366-73 - PubMed
  8. J Proteome Res. 2004 Mar-Apr;3(2):179-96 - PubMed
  9. Nat Med. 2004 Jun;10(6):594-601 - PubMed
  10. Brief Funct Genomic Proteomic. 2003 Oct;2(3):175-84 - PubMed
  11. J Proteome Res. 2004 May-Jun;3(3):345-9 - PubMed
  12. Comp Med. 2004 Dec;54(6):635-44 - PubMed
  13. Biosystems. 2006 Feb-Mar;83(2-3):81-90 - PubMed
  14. Bioinformatics. 2006 Aug 1;22(15):1924-5 - PubMed
  15. Pharmacogenomics. 2006 Oct;7(7):1087-94 - PubMed
  16. Cancer Res. 2006 Nov 15;66(22):10795-804 - PubMed
  17. Chest. 2007 Sep;132(3 Suppl):234S-242S - PubMed
  18. Trends Plant Sci. 2008 Apr;13(4):165-71 - PubMed
  19. Nature. 2008 Apr 3;452(7187):580-9 - PubMed
  20. Chem Rev. 2008 May;108(5):1501-16 - PubMed
  21. J Am Coll Cardiol. 2008 Jul 8;52(2):117-23 - PubMed
  22. BMC Syst Biol. 2008 Aug 12;2:74 - PubMed
  23. J Nucl Med. 2008 Dec;49(12):1928-35 - PubMed
  24. Nat Rev Genet. 2009 Jan;10(1):57-63 - PubMed
  25. Expert Opin Med Diagn. 2008 Jul;2(7):829-842 - PubMed
  26. Clin Cancer Res. 2009 Jan 15;15(2):431-40 - PubMed
  27. J Nucl Med. 2009 Feb;50(2):239-49 - PubMed
  28. Eur J Radiol. 2009 May;70(2):232-41 - PubMed
  29. Genome Med. 2009 Jan 20;1(1):2 - PubMed
  30. Mol Syst Biol. 2009;5:273 - PubMed
  31. Br J Cancer. 2009 Nov 3;101(9):1565-73 - PubMed
  32. Occup Environ Med. 2010 Feb;67(2):136-43 - PubMed
  33. Genes Dev. 2010 Mar 1;24(5):423-31 - PubMed
  34. Nat Methods. 2010 Mar;7(3 Suppl):S56-68 - PubMed
  35. J Clin Oncol. 2010 Jun 1;28(16):2777-83 - PubMed
  36. Annu Rev Anal Chem (Palo Alto Calif). 2008;1:1-43 - PubMed
  37. Semin Radiat Oncol. 2010 Jul;20(3):149-55 - PubMed
  38. Cold Spring Harb Perspect Biol. 2010 Dec;2(12):a003848 - PubMed
  39. Curr Opin Biotechnol. 2011 Feb;22(1):3-8 - PubMed
  40. Adv Drug Deliv Rev. 2011 Jun 19;63(7):547-54 - PubMed
  41. Hum Genomics Proteomics. 2009 Dec 08;2009:null - PubMed
  42. Cancer Immunol Immunother. 2011 Mar;60(3):319-26 - PubMed
  43. Radiology. 2011 Feb;258(2):571-82 - PubMed
  44. Adv Bioinformatics. 2010;:268925 - PubMed
  45. Nat Rev Clin Oncol. 2011 Mar;8(3):184-7 - PubMed
  46. Biochim Biophys Acta. 2011 Jun;1807(6):650-63 - PubMed
  47. Radiology. 2011 Jun;259(3):633-40 - PubMed
  48. Int J Mol Imaging. 2011;2011:796025 - PubMed
  49. Circ Res. 2011 May 27;108(11):1381-91 - PubMed
  50. Biomaterials. 2011 Oct;32(29):7127-38 - PubMed
  51. Prog Biophys Mol Biol. 2011 Aug;106(2):337-9 - PubMed
  52. Acc Chem Res. 2011 Oct 18;44(10):1050-60 - PubMed
  53. Lab Invest. 2012 Jan;92(1):4-8 - PubMed
  54. Virchows Arch. 2012 Jan;460(1):3-8 - PubMed
  55. J Ethnopharmacol. 2012 Apr 10;140(3):535-44 - PubMed
  56. Cell. 2012 Mar 16;148(6):1293-307 - PubMed
  57. N Biotechnol. 2012 Sep 15;29(6):613-24 - PubMed
  58. Mol Oncol. 2012 Apr;6(2):182-95 - PubMed
  59. Physiol Rev. 2012 Apr;92(2):897-965 - PubMed
  60. BMC Bioinformatics. 2012 May 01;13:71 - PubMed
  61. Biotechnol J. 2012 Aug;7(8):992-1001 - PubMed
  62. Int Microbiol. 2012 Jun;15(2):55-60 - PubMed
  63. Curr Opin Pharmacol. 2012 Oct;12(5):623-8 - PubMed
  64. Hepatology. 2013 May;57(5):2072-7 - PubMed
  65. Am J Pathol. 2013 Feb;182(2):312-8 - PubMed
  66. Clin Biochem. 2013 Apr;46(6):524-38 - PubMed
  67. Phys Chem Chem Phys. 2013 Apr 21;15(15):5329-44 - PubMed
  68. Rambam Maimonides Med J. 2013 Apr 30;4(2):e0012 - PubMed
  69. Adv Drug Deliv Rev. 2014 Feb;66:90-100 - PubMed
  70. Nat Rev Clin Oncol. 2014 Mar;11(3):167-76 - PubMed
  71. Biomed Res Int. 2014;2014:819324 - PubMed
  72. Am J Nucl Med Mol Imaging. 2014 Mar 20;4(2):202-12 - PubMed
  73. Metabolites. 2013 Jul 05;3(3):552-74 - PubMed
  74. Int J Radiat Oncol Biol Phys. 2014 Jul 15;89(4):709-13 - PubMed
  75. Biomed Res Int. 2014;2014:428570 - PubMed
  76. Nucl Med Commun. 2014 Dec;35(12):1193-6 - PubMed
  77. Adv Cancer Res. 2014;124:235-56 - PubMed
  78. N Engl J Med. 2015 Feb 26;372(9):793-5 - PubMed
  79. Metabolites. 2015 Feb 16;5(1):100-18 - PubMed
  80. J Clin Oncol. 2015 Nov 20;33(33):3880-6 - PubMed
  81. J Am Coll Radiol. 2015 Oct;12(10):1106-11 - PubMed
  82. J Nucl Med. 2016 Feb;57(2):171-2 - PubMed
  83. Radiology. 2016 Apr;279(1):226-38 - PubMed
  84. Rinsho Byori. 2015 Apr;63(4):450-6 - PubMed
  85. Proc Natl Acad Sci U S A. 1977 Feb;74(2):560-4 - PubMed
  86. Eur J Radiol. 2015 Dec;84(12):2345-6 - PubMed
  87. Cardiology. 2016;133(3):178-80 - PubMed
  88. J Pers Med. 2016 Jan 07;6(1):null - PubMed
  89. J Pers Med. 2016 Jan 20;6(1):null - PubMed
  90. J Pers Med. 2016 Jan 21;6(1):null - PubMed
  91. J Pers Med. 2016 Feb 27;6(1):null - PubMed
  92. J Pers Med. 2016 May 02;6(2):null - PubMed
  93. Curr Pharm Des. 2016;22(34):5234-5248 - PubMed
  94. Biomed Res Int. 2016;2016:1680464 - PubMed
  95. Quant Biol. 2016 Mar;4(1):1-12 - PubMed

Publication Types